Key result
Goal-directed therapy significantly reduced overall mortality (OR 0.52) and complication rates (OR 0.45) in patients undergoing major surgery, though the mortality benefit was confined to the extremely high-risk subgroup.
Why the study?
Does perioperative goal-directed therapy reduce mortality and complications in adult patients undergoing major non-cardiac surgery?
Meta-Analysis (n=2,808)
Does perioperative goal-directed therapy reduce mortality and complications in adult patients undergoing major non-cardiac surgery?
Odds Ratio: 0.52 (95% CI 0.36–0.74)
p-value: p=0.003
Perioperative goal-directed therapy reduces complications in all patients undergoing major non-cardiac surgery, but survival benefits are limited to those at extremely high risk of death.
No takes yet. Share an insight, caveat, or question.
Supports GDT to reduce complications in major non-cardiac surgery; confirms mortality benefit limited to extremely high-risk patients.
Cecconi et al. (2012) conducted a meta-analysis in Major non-cardiac surgery (n=2,808). Goal-directed therapy (GDT) vs. Standard care was evaluated on Hospital mortality (OR 0.52, 95% CI 0.36 to 0.74, p=0.003). Goal-directed therapy significantly reduced overall mortality (OR 0.52) and complication rates (OR 0.45) in patients undergoing major surgery, though the mortality benefit was confined to the extremely high-risk subgroup.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: